Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina. Biomol Biomed [Internet]. 2024 Sep. 6 [cited 2025 May 2];24(5):1400–1406. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10433